Lv21
170 积分 2024-03-07 加入
Emerging molecular targets in gynaecologic cancers: clinical implications for personalized therapy
2小时前
待确认
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis
1天前
已完结
BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study
3天前
已完结
Recent advances in trophoblast cell‐surface antigen 2 targeted therapy for solid tumors
6天前
已完结
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance
9天前
已完结
Cancer burden and control in China: landscape, trends and challenges
9天前
已完结
Characteristics of Clinical Trials Evaluating Biosimilars in the Treatment of Cancer
16天前
已完结
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis
16天前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
19天前
已完结
Targetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations
20天前
已完结
皖公网安备34019202002308
